These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 705763)

  • 1. Liver cirrhosis and steatosis comparison of the severity of biochemical changes.
    Fassati P; Horejsi J; Jezkova Z; Spizek J
    Tijdschr Gastroenterol; 1978; 21(2):113-22. PubMed ID: 705763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis of fatty liver].
    Thaler H
    Dtsch Med Wochenschr; 1966 Dec; 91(48):2171-2. PubMed ID: 5923858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis of fatty liver].
    Rommel K; Török M
    Med Welt; 1967 Nov; 46():2743-6. PubMed ID: 5606409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic hepatitis and cirrhosis of the liver in children].
    Malakhovskiĭ IuE
    Vopr Okhr Materin Det; 1973 Sep; 18(9):3-9. PubMed ID: 4593539
    [No Abstract]   [Full Text] [Related]  

  • 5. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):295-302. PubMed ID: 7180579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
    Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liver function test after nicotinic acid loading. I. A clinical study].
    Finck C; Jorke D
    Acta Hepatosplenol; 1968; 15(5):315-21. PubMed ID: 5707324
    [No Abstract]   [Full Text] [Related]  

  • 8. [Noninvasive tools for the diagnosis of steatosis and fibrosis in patients with NAFLD].
    Castera L
    Gastroenterol Clin Biol; 2009 May; 33(5):405-12. PubMed ID: 19349131
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease.
    Nilsson LH; Hultman E
    Scand J Gastroenterol; 1974; 9(3):319-23. PubMed ID: 4850181
    [No Abstract]   [Full Text] [Related]  

  • 10. [Excretion rate of indocyanine green in liver diseases of various severity].
    Teichmann W; Brügmann E; Schulz H
    Orv Hetil; 1973 May; 114(20):1170-1. PubMed ID: 4704298
    [No Abstract]   [Full Text] [Related]  

  • 11. The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis.
    Saadeh S; Younossi ZM
    Cleve Clin J Med; 2000 Feb; 67(2):96-7, 101-4. PubMed ID: 10680276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regression of fatty liver].
    Thaler H
    Dtsch Med Wochenschr; 1989 Aug; 114(31-32):1224. PubMed ID: 2666084
    [No Abstract]   [Full Text] [Related]  

  • 13. [The prophylactic value of ambulatory liver biopsy].
    Frank H; Leodolter I
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):313-6. PubMed ID: 5731585
    [No Abstract]   [Full Text] [Related]  

  • 14. [Steatosis and cirrhosis secondary to insulin resistance in children. Possible physiopathological mechanisms].
    Bonet Serra B; Barrio Merino A; Quintanar Rioja A; Alavés Buforn M; Nevado Santos M
    An Esp Pediatr; 2002 Apr; 56(4):353-6. PubMed ID: 11927081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971].
    Schmidt R; Tennstedt A
    Z Arztl Fortbild (Jena); 1974 Mar; 68(6):298-302. PubMed ID: 4418773
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limitation of the indication for laparoscopy and percutaneous liver biopsy in liver diseases].
    Wildhirt E
    Med Klin; 1969 Feb; 64(7):287-9. PubMed ID: 5769480
    [No Abstract]   [Full Text] [Related]  

  • 18. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    Pagadala M; Zein CO; McCullough AJ
    Clin Liver Dis; 2009 Nov; 13(4):591-606. PubMed ID: 19818307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of plasma D(-)-lactate, diamine oxidase and endotoxin in patients with liver cirrhosis.
    Ruan P; Gong ZJ; Zhang QR
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):58-61. PubMed ID: 14969839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.